The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review
Authors
Keywords
Health economics, Cost-effectiveness analysis, Lyme disease, Antibiotics, Economic analysis, Vaccination and immunization, Economics, Indirect costs
Journal
PLoS One
Volume 14, Issue 1, Pages e0210280
Publisher
Public Library of Science (PLoS)
Online
2019-01-05
DOI
10.1371/journal.pone.0210280
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Need for a New Lyme Disease Vaccine
- (2016) Stanley A. Plotkin NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiology of Lyme Disease
- (2015) Paul S. Mead INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Epidemiology and cost of hospital care for Lyme borreliosis in Germany: Lessons from a health care utilization database analysis
- (2015) B. Lohr et al. Ticks and Tick-Borne Diseases
- Health Care Costs, Utilization and Patterns of Care following Lyme Disease
- (2015) Emily R. Adrion et al. PLoS One
- Initial and Long-Term Costs of Patients Hospitalized with West Nile Virus Disease
- (2014) J. Erin Staples et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Lyme Disease Testing by Large Commercial Laboratories in the United States
- (2014) Alison F. Hinckley et al. CLINICAL INFECTIOUS DISEASES
- CDC Estimates 300 000 US Cases of Lyme Disease Annually
- (2013) Bridget M. Kuehn JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparative Cost-Effectiveness of Two-Tiered Testing Strategies for Serodiagnosis of Lyme Disease with Noncutaneous Manifestations
- (2013) G. P. Wormser et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
- (2013) Don Husereau et al. VALUE IN HEALTH
- Empiric Antibiotic Treatment of Erythema Migrans-Like Skin Lesions As a Function of Geography: A Clinical and Cost Effectiveness Modeling Study
- (2013) Paul M. Lantos et al. VECTOR-BORNE AND ZOONOTIC DISEASES
- Vaccines against Lyme Disease: What Happened and What Lessons Can We Learn?
- (2011) Gregory A. Poland CLINICAL INFECTIOUS DISEASES
- A Safe and Cost-Effective Approach to Treating Lyme Cardiac Disease in an Era of Health Care Reform
- (2011) JOONHYUK KIM et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- Neuroborreliosis—an epidemiological, clinical and healthcare cost study from an endemic area in the south-east of Sweden
- (2009) A.J. Henningsson et al. CLINICAL MICROBIOLOGY AND INFECTION
- WHO Guide for standardisation of economic evaluations of immunization programmes
- (2009) Damian G. Walker et al. VACCINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More